Physician
Lowry Pediatrics, PC
Lowry Pediatrics, PC was paid $4.41M by Medicaid between Jan 2018 and Dec 2024, across 84 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 28% of everything it billed.
33Billing provider infoLOWRY PEDIATRICS, PC
DENVER, CO 80230
DENVER, CO 80230
33aNPI1912133356assigned 05/29/2009
33bProvider typePediatrics Physician
28Total paid$4.41M
24GClaims116,189
24DCodes billed84
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Colorado
Rank by total paid#8 of 186
Median peer was paid$68K
This provider vs. median65×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,708 | $435K | |
| 2019 | 11,379 | $501K | |
| 2020 | 12,763 | $527K | |
| 2021 | 18,716 | $631K | |
| 2022 | 22,296 | $718K | |
| 2023 | 24,947 | $921K | |
| 2024incomplete | 16,380 | $673K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 28% | 12,926 | 11,443 | $1.22M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 12% | 6,087 | 5,417 | $517K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 11% | 5,082 | 4,903 | $465K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.6% | 5,138 | 4,732 | $333K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.5% | 3,125 | 3,029 | $285K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 4.8% | 11,710 | 11,084 | $213K |
| H0025 | Behavioral health prevention education service (delivery of services with target population to affect knowledge, attitude and/or behavior) | 4.3% | 1,407 | 1,219 | $191K |
| 92587 | 4.2% | 5,388 | 5,247 | $186K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.3% | 1,465 | 1,406 | $146K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 2.8% | 6,818 | 6,493 | $124K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.6% | 3,149 | 3,021 | $116K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.7% | 3,748 | 3,434 | $76K |
72 more codes
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 1.2% | 4,982 | $52K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.1% | 3,043 | $48K |
| 99215 | Doctor's office visit, returning patient (complex) | 1.0% | 354 | $46K |
| 99381 | <1% | 447 | $42K | |
| 96127 | <1% | 2,142 | $34K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 766 | $32K |
| 99173 | <1% | 3,992 | $29K | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 992 | $29K |
| 90474 | <1% | 2,427 | $26K | |
| H0023 | Behavioral health outreach service (planned approach to reach a targeted population) | <1% | 149 | $22K |
| 36406 | <1% | 1,847 | $16K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 852 | $16K |
| 90651 | <1% | 645 | $14K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 969 | $14K |
| 90670 | <1% | 2,339 | $14K | |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 327 | $10K |
| 90734 | <1% | 449 | $8K | |
| 90480 | <1% | 155 | $6K | |
| D1206 | Topical application of fluoride varnish | <1% | 387 | $6K |
| 90698 | <1% | 2,201 | $6K | |
| 90710 | <1% | 498 | $5K | |
| 0071A | <1% | 100 | $5K | |
| 99382 | <1% | 46 | $4K | |
| 85018 | <1% | 1,712 | $4K | |
| 90680 | <1% | 1,892 | $4K | |
| 94760 | <1% | 2,089 | $3K | |
| 0072A | <1% | 52 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 161 | $3K |
| 90633 | <1% | 1,468 | $3K | |
| 99383 | <1% | 27 | $3K | |
| 90716 | <1% | 571 | $3K | |
| 90677 | <1% | 433 | $3K | |
| 99000 | <1% | 1,871 | $2K | |
| 90688 | <1% | 1,982 | $2K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 17 | $2K |
| 99384 | <1% | 14 | $2K | |
| 90715 | <1% | 285 | $2K | |
| 90707 | <1% | 542 | $1K | |
| 90696 | <1% | 434 | $1K | |
| 90744 | <1% | 1,491 | $1K | |
| 0081A | <1% | 16 | $741.24 | |
| 0001A | <1% | 16 | $729.47 | |
| 99460 | <1% | 13 | $681.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 31 | $540.60 |
| 36410 | <1% | 66 | $538.59 | |
| 99441 | <1% | 34 | $500.82 | |
| 90687 | <1% | 1,043 | $462.96 | |
| 94010 | <1% | 15 | $462.15 | |
| 90700 | <1% | 320 | $428.30 | |
| 90658 | <1% | 101 | $337.65 | |
| 96380 | <1% | 14 | $296.38 | |
| 94664 | <1% | 49 | $243.55 | |
| 99070 | <1% | 19 | $160.68 | |
| 91319 | <1% | 37 | $136.40 | |
| 81002 | <1% | 98 | $124.51 | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 77 | $69.02 |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 62 | $60.34 |
| 91318 | <1% | 22 | $40.00 | |
| 96161 | <1% | 1,356 | $31.59 | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 128 | $26.56 |
| 90656 | <1% | 322 | $23.53 | |
| 87280 | <1% | 107 | $22.81 | |
| 90648 | <1% | 234 | $15.35 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 118 | $0.36 |
| 99051 | 0% | 43 | $0.00 | |
| 91300 | 0% | 81 | $0.00 | |
| 99188 | 0% | 332 | $0.00 | |
| 91308 | 0% | 24 | $0.00 | |
| 91320 | 0% | 14 | $0.00 | |
| 98960 | 0% | 19 | $0.00 | |
| 91307 | 0% | 172 | $0.00 | |
| 90381 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMERENSTEIN, SCOTT (PHYSICIAN OWNER)